Raymond James Financial’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.93M Buy
465,895
+19,284
+4% +$208K ﹤0.01% 2468
2026
Q1
$3.78M Buy
446,611
+9,815
+2% +$107K ﹤0.01% 2814
2025
Q4
$4.93M Buy
436,796
+344,751
+375% +$4.27M ﹤0.01% 2524
2025
Q3
$1.38M Buy
92,045
+59,431
+182% +$865K ﹤0.01% 3458
2025
Q2
$460K Buy
32,614
+9,443
+41% +$168K ﹤0.01% 4061
2025
Q1
$557K Sell
23,171
-13,862
-37% -$489K ﹤0.01% 3877
2024
Q4
$1.38M Buy
+37,033
New +$1.73M ﹤0.01% 3232

Other funds holding BHVN

Raymond James Financial's BHVN Position: Q2 2026 in Review

Raymond James Financial increased its Biohaven (BHVN) stake by 4.3% in Q2 2026, buying an estimated $208K and bringing the position to 465,895 shares worth $6.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

Raymond James Financial first reported a position in BHVN in Q4 2024 and has held it in 7 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Raymond James Financial held 465,895 shares of Biohaven worth $6.93M as of Q2 2026.
  • Raymond James Financial bought 19,284 Biohaven shares in Q2 2026, an estimated $208K.
  • Biohaven made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2468 holding.
  • Raymond James Financial first reported a position in Biohaven in Q4 2024 and has held it in 7 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.